Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Events
    • Recent News
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Events
  • Recent News

DelMar Pharmaceuticals to Present at the 26th Annual ROTH Capital Conference

Mar 4, 2014

DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial

Feb 26, 2014

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Dec 9, 2013

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com December 5th

Dec 2, 2013

DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting

Nov 22, 2013

DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology

Nov 14, 2013

DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers

Oct 21, 2013

DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting

Oct 15, 2013

DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients

Oct 9, 2013

DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV

Sep 19, 2013
    • 1...
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    © 2022 Kintara Therapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences